ICER Releases Draft Report on Disease-modifying Therapies for MS, Welcomes Comment
The Institute for Clinical and Economic Review (ICER) has released a Draft Evidence Report evaluating the comparative clinical effectiveness and…
Articles by Patricia Silva, PhD
Protein from Parasite Lowers Relapse Rates, Evidence of Demyelination in Mice with MS
A molecule secreted by a parasite was seen to prevent autoimmune reactions in a mouse model of multiple sclerosis (MS). As this…
UV Light May Lead Way to New Treatment for MS and Inflammation
Researchers have found a way to harness inflammation with the help of ultraviolet (UV) light, making it possible to design an…
RSNA 2016: Philips to Debut Advanced Software Applications to Evaluate Neurological Disorders
Royal Philips will introduce a new suite of magnetic resonance (MR)-based software applications at the upcoming Radiological Society of North America’s…
Australian Researcher Honored for Discovery That May Lead to Anti-Inflammatory Therapy
Dr. Rebecca Coll, a young researcher at the University of Queensland Institute of Molecular Bioscience, won the 2016 Research Australia…
MS Foundation Launches New Website and Redesigns Focus Magazine
The Multiple Sclerosis Foundation, which is celebrating its 30th anniversary this year, has launched a new website to make…
New Company Specializing in Stem Cell Platform for MS and Other Ills Raises $48.5M
Magenta Therapeutics has completed its first round of financing, raising $48.5 million to develop ways of bringing bone marrow stem cell transplants…
Discovery MS Launches in North Carolina with Series of Research Efforts
Discovery MS, a nonprofit research initiative based at the David H. Murdock Research Institute (DHMRI) in North Carolina, had its official…
AXIM Biotech to Get U.S. Patent Covering All Cannabinoids in Its Chewing Gums
AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) will be issuing a patent covering all cannabinoids —…
Assay Able to Detect Neuron Damage in Blood May Serve as Early MS Diagnostic Tool
Quanterix and UmanDiagnostics are working to advance an assay capable of detecting neuron damage in a blood sample — a tool…
New Way of Scanning Brain Captures Onset of Inflammation in MS Mice and Patients
Advances in brain imaging are making it possible to visualize early and ongoing events in multiple sclerosis (MS) — beginning with…
Availability of MS Therapies Provides ‘Peace of Mind’ Value to Society, Study Finds
Chronic diseases like multiple sclerosis (MS) not only impact patients, they also inspire fear among healthy people who may be…
Men and Women Seen to Differ in Genetic Susceptibility to MS and Its Progression in Study
Researchers in Russia found for a first time an association between variants in GAL, a gene that codes for the…
UK Announces New Employment Support Package for Health-Disabled People
The British government announced on Oct. 31 that a new Personal Support Package will be available for people with health…
Gene Test May Predict Which MS Patients Will Respond to Interferon-beta Therapy
In multiple sclerosis (MS) patients who do not respond to interferon-beta treatment, autoimmunity may depend on processes that differ from patients…
University Researchers Develop Tool to Diagnose Serious Weight Loss in Patients with MS, Cancer
Researchers at McGill University Health Centre (MUHC) in Canada developed a new tool to diagnose cachexia — also called…
Plans by 4 Countries to Subsidize Cost of Newer MS Drugs May Weight on US
A cost-effectiveness analysis of reimbursement recommendations for four relatively new multiple sclerosis (MS) treatments made by agencies in four countries —…
Testing Stages of Marijuana Gum to Treat Spasticity in MS Can Be Followed Online
Medical Marijuana announced that Axim Biotechnologies, a cannabinoid-based product developer in which it owns a strategic interest, has released a product pipeline…
ABLE Act Webinar Set for Nov. 15
The National Disability Institute manages the website www.ablenrc.org that has good information. I watched all the “webinars” and found…
MS Patients Fall Ill Earlier in World’s Northern Regions
A large international research effort concluded that the geographical area where a person lives affects how early they will start…
NIH Researcher Working on MS Imaging Wins 2016 Barancik Prize for Innovation
Dr. Daniel Reich, a researcher with the National Institutes of Health (NIH), has been recognized for his pioneering work on brain…
ABLE Accounts: Comparing Plans in 3 States Open to All
ABLE Accounts and Amendments In my previous column, I introduced the exciting new program for people…
Myelin May Hold Raw Material for Immunizing MS Patients Against Demyelination
Immunization with molecules present specifically in myelin may be a new approach to treating multiple sclerosis (MS), according to a…
MS Foundation Will Host Bourbon and Blues 30th Anniversary Gala on Dec. 3
The Multiple Sclerosis Foundation, celebrating its 30th anniversary of serving the multiple sclerosis (MS) community, will host the…
GNS Unveils Platform to Predict New Therapy’s Likely Success in Real World at ISPOR
GNS Healthcare is presenting a data-driven causal machine learning solution, called Efficacy to Effectiveness, designed to predict how potential therapies will actually perform…
PoNS Tongue Stimulator, Designed to Ease Neuroplasticity, Recommended for ISO Certification
Helius Medical Technologies‘s Portable Neuromodulation Stimulator (PoNS), a device being developed to treat neuroplasticity in people with multiple sclerosis (MS) and…
AXIM Moving Ahead with Testing of Cannabinoid Products, Including Chewing Gum for MS Patients
AXIM Biotechnologies announced it has secured financing from private sources to continue its testing of medical cannabinoid products as potential…
Getting More Blacks and Other Minority MS Patients into Clinical Studies Is Goal of ACP Project
Getting more African-Americans and other minority groups to take part in clinical research into treatments for multiple sclerosis (MS), and identifying…
Selexis to Provide ImmuNext with Cell Lines for Research into Treatment for MS, Autoimmune Diseases
Selexis has entered into a commercial arrangement with ImmuNext, providing that company with access to research cell banks from its SURE technology Platform…
Medical Marijuana in the Form of Controlled-dose Capsules Now Available in New York
Columbia Care announced the launch of its line of pills for medical marijuana — calling it the first controlled-dose, pharmaceutical-quality…